Biopsafe ApS: Financial statements 2025
CVR: 33575505
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Biopsafe ApS (CVR 33575505) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 14,274,000 and a net result of DKK 6,231,000 compared with DKK 4,087,000 the year before. That is an increase of 26.6% compared with the year before. Equity in the 2025 report amounted to DKK 11,231,000. The solvency ratio was 46.9%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 14,274,000
- Profit/Loss
- DKK 6,231,000
- Equity
- DKK 11,231,000
- Total Assets
- DKK 23,929,000
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 14.3 mio. | 6.2 mio. | 11.2 mio. | 4 |
| 2024 | - | 11.3 mio. | 4.1 mio. | 9.1 mio. | 3 |
| 2023 | - | 7.2 mio. | 79 t. | 5.1 mio. | 4 |
| 2022 | - | 6.1 mio. | 1.4 mio. | 5.7 mio. | 2 |
| 2021 | - | 7.5 mio. | 250 t. | 4.3 mio. | 3 |
Official annual report
How creditworthy is Biopsafe ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Biopsafe ApS has published its annual report for 2024. Gross profit came to DKK 11,278,000, and the net result was DKK 4,087,000.
About Biopsafe ApS
Biopsafe ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2011. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named AX-LAB INNOVATION ApS. The management consists of Anne Lykke Gade. The board consists of Anders Dahlberg. The company is owned by MedCap AB (publ). The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 14,274,000 and a net result of DKK 6,231,000 compared with DKK 4,087,000 the year before. Equity in the 2025 report amounted to DKK 11,231,000.